UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057210
Receipt number R000065334
Scientific Title Open dialogue approach to support decision-making for older adults with dementia: feasibility study
Date of disclosure of the study information 2025/03/05
Last modified on 2025/03/26 14:17:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open dialogue approach to support decision-making for older adults with dementia: feasibility study

Acronym

Open dialogue approach to support decision-making for older adults with dementia: feasibility study

Scientific Title

Open dialogue approach to support decision-making for older adults with dementia: feasibility study

Scientific Title:Acronym

Open dialogue approach to support decision-making for older adults with dementia: feasibility study

Region

Japan


Condition

Condition

Mild cognitive disorder, dementia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examining the feasibility of open dialogue-style dialogue practice to supporting decision-making for old elders with dementia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Pre- and post-intervention interviews with older adults with dementia and their families to assess the extent to which conflicts were resolved and their satisfaction with the intervention, and post-intervention interviews with staff to assess implementation difficulties and burden.

Key secondary outcomes

Families' background: age, sex, relationship to the patient (obtained from medical
records pre-intervention)
Patient information: age, sex, diagnosis, presence of inhabitant (obtained from
medical records pre-intervention)
Severity of dementia (using Clinical Dementia Scale pre-intervention)
Patient's cognitive function (using Mini-Mental State Examination pre-
intervention)
Patient's ADL (using Physical Self-Maintenance Scale pre-intervention)
Patient's neuropsychiatric symptoms (using Neuropsychiatric Inventory before
the intervention, at the end of the intervention, and 2 months after the end of
the intervention)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Open dialogic practices

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

MCI
Aged 60 years or older
Clinically diagnosed with MCI by a doctor
CDR is 0.5
Living at home
Conflicts with family members in decision-making
Able to obtain written consent from the individual to participate in the study
of their own free will

Early dementia
Aged 60 years or older
Clinically diagnosed with dementia by a doctor
CDR is 1.0
Living at home
Conflicts with family members in decision-making
Able to obtain written consent from the individual to participate in the study
of their own free will

Family
Conflicts with patient in decision-making (No relationship to the patient is required)
Able to obtain written consent from the individual to participate in the study
of their own free will

Key exclusion criteria

MCI
dementia
history of mental disorder
traumatic brain injury, or alcohol or other drug abuse
mental retardation, and severe communication disabilities such as visual or
hearing impairment

Early dementia
history of mental disorder
traumatic brain injury, or alcohol or other drug abuse
mental retardation, and severe communication disabilities such as visual or
hearing impairment

Family
history of mental disorder
traumatic brain injury, or alcohol or other drug abuse
mental retardation, and severe communication disabilities such as visual or
hearing impairment

Target sample size

2


Research contact person

Name of lead principal investigator

1st name Yuka
Middle name
Last name Kato

Organization

Graduate school of medical science, Kyoto prefectural university of medicine

Division name

Department of psychiatry

Zip code

6028566

Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto

TEL

0752515612

Email

y-kato@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Yuka
Middle name
Last name Kato

Organization

Graduate school of medical science, Kyoto prefectural university of medicine

Division name

Department of psychiatry

Zip code

6028566

Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto

TEL

0752515612

Homepage URL


Email

y-kato@koto.kpu-m.ac.jp


Sponsor or person

Institute

Graduate school of medical science, Kyoto prefectural university of medicine

Institute

Department

Personal name



Funding Source

Organization

Department of psychiatry, graduate school of medical science, Kyoto prefectural university of medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Psychiatry, graduate school of medical science, Kyoto prefectural university of medicine

Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto

Tel

0752515612

Email

psyche@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 03 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 03 Month 05 Day

Date of IRB


Anticipated trial start date

2025 Year 04 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 03 Month 05 Day

Last modified on

2025 Year 03 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065334